China–Chile FTA – Origin Accumulation Pharmaceutical Products

Quelle: https://www.wto.org/english/res_e/reser_e/ersd201301_e.htm

The China–Chile Free Trade Agreement (FTA) allows for origin accumulation for pharmaceutical products, meaning that products can be considered originating goods under certain conditions if they are produced using materials sourced from both countries.

Related Terms

You might also be interested in these terms

China–Chile FTA

The China–Chile FTA is a trade agreement that reduces tariffs and trade barriers between China and Chile to promote bilateral trade.

Learn more

CPTPP – Origin Accumulation Pharmaceutical Products

The CPTPP origin accumulation refers to a regulation under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership that allows pharm...

Learn more

China–Chile FTA – Origin Accumulation Toys

The China-Chile Free Trade Agreement allows for origin accumulation for toys, meaning that materials from China and Chile can be combined to meet orig...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more

China-Chile FTA – Origin Accumulation Furniture

The origin accumulation under the China-Chile Free Trade Agreement allows for the use of materials and components from both countries to meet the orig...

Learn more